Molecular profiling of post-menopausal women with breast cancer on neoadjuvant endocrine therapy with tamoxifen or exemestane.

Trial Profile

Molecular profiling of post-menopausal women with breast cancer on neoadjuvant endocrine therapy with tamoxifen or exemestane.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jul 2014

At a glance

  • Drugs Exemestane; Tamoxifen
  • Indications Breast cancer
  • Focus Biomarker; Therapeutic Use
  • Acronyms MoNET
  • Most Recent Events

    • 24 Feb 2011 Planned end date changed from 1 Jan 2010 to 1 May 2011 as reported by ISRCTN: Current Controlled Trials.
    • 22 Feb 2011 Status changed from recruiting to completed, as reported by Current Controlled Trials.
    • 20 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top